Limbach Genetics GmbH | Medizinische Genetik Mainz

What Limbach Genetics GmbH | Medizinische Genetik Mainz does

Limbach Genetics GmbH | Medizinische Genetik Mainz operates as a German Medical Care Center (Medizinisches Versorgungszentrum, MVZ) specializing in human genetics, headquartered at Haifa-Allee 38, Mainz. The facility delivers genetic counseling and diagnostic services to patients, referring physicians, medical practices, and hospitals, with a particular focus on rare and hereditary diseases, prenatal diagnostics, and preventive genetic testing. Services are led by an interdisciplinary team of board-certified human genetics specialists (Fachärzte für Humangenetik) under Medical Director Prof. Dr. Carsten Bergmann, who is also a shareholder.

The core technical stack is molecular genetic diagnostics built on Next-Generation Sequencing (NGS), with Whole Exome Sequencing (WES), multi-gene panels, and Copy Number Variant (CNV) detection as the primary products; WGS and RNAseq are noted as advanced modalities. Sample intake and result delivery use FTAPI for end-to-end encrypted data transfer, video consultations run on Cisco WebEx or Zoom, and patient scheduling is integrated with Doctolib. The center also participates in federally funded research, notably the BMBF-funded NEOCYST consortium on early-onset cystic kidney disease, and is a founding member of the Nationale Allianz für seltene genetische Erkrankungen (NASGE).

The business model is fee-for-service clinical reimbursement: genetic counseling and diagnostics are billed primarily through German statutory health insurance (Kassenleistung) under EBM Chapter 11, with private insurance (PKV) as a secondary stream, plus non-recurring BMBF research grants. Customer acquisition is hybrid, relying on physician referral networks, direct patient self-service via Doctolib, and Limbach Gruppe SE ecosystem channels. The company is a subsidiary operating unit within Limbach Gruppe SE, one of the largest laboratory groups in Germany and Europe, with co-shareholder Augenklinik Dardenne SE.

Name

Limbach Genetics GmbH | Medizinische Genetik Mainz

Legal name

Limbach Genetics eGbR

Website

https://medgen-mainz.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

MVZ Medizinische Genetik Mainz is a German medical genetics center providing NGS-based genetic counseling, diagnostics (WES, gene panels, prenatal, preventive), and research services to patients, physicians, and hospitals, operating within the Limbach Gruppe SE laboratory network.

Ownership category

akta.pro rank

Product category

Medical Genetic Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Medical genetic diagnostics
• Human genetic counseling
• Next-generation sequencing
• Whole exome sequencing
• Prenatal genetic testing

Headquarters

HQ city

Mainz

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Genetic Diagnostic Services (Statutory Health Insurance): Genetic counseling and diagnostic services are covered as statutory health insurance benefits (Kassenleistung) in Germany under EBM Chapter 11. Genetic services do not affect the laboratory budget or economic-efficiency bonus under EBM Chapter 32.
2. Private Health Insurance Billing: Services are also billed to private health insurance providers. Cost estimates are provided in advance or sent with sample confirmation.
3. BMBF Research Funding: Research funding from the German Federal Ministry of Education and Research (BMBF) for the NEOCYST project on cystic kidney disease research (Förderkennzeichen 01GM1903G)

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

MVZ Medizinische Genetik Mainz is a medical genetics center providing molecular genetic diagnostics, human genetic counseling, and preventive/prenatal genetic testing. The core diagnostic services are powered by Next-Generation Sequencing (NGS) technology, including Whole Exome Sequencing (WES), multi-gene panels, and Copy Number Variant (CNV) detection, delivered to patients, physicians, and hospitals in Mainz and remotely via video consultation.

Product overview

MVZ Medizinische Genetik Mainz operates as a medical genetics center providing a comprehensive suite of genetic diagnostic services. The core offering centers on molecular genetic diagnostics using Next-Generation Sequencing (NGS) technology, encompassing Whole Exome Sequencing (WES), Multi-Gene Panels, prenatal diagnostics, and preventive diagnostics. These are complemented by genetic counseling services (Humangenetische Beratung) and video consultation capabilities (Videosprechstunde). The facility also offers a Test Directory (Leistungsverzeichnis) cataloging all available tests. Services are delivered to both patients (via direct appointment booking through Doctolib) and referring physicians (via request forms and specialized diagnostic pathways), with secure data upload via FTAPI.

Differentiator

Problem solved

Functional benefit

Products and services

• Molekulargenetische Diagnostik (Molecular Genetic Diagnostics) Core genetic testing service using Next-Generation Sequencing (NGS) technology to identify genetic causes of diseases through DNA analysis, including single nucleotide variants (SNVs) and copy number variants (CNVs), for patients, physicians, and hospitals.
• Whole Exome Sequencing (WES) Comprehensive analysis of all coding sequences of a patient's genome, particularly helpful for complex, non-specific disorders where targeted gene panel testing is not expedient or previous testing did not yield a diagnosis; includes reliable determination of CNVs and complex genomic rearrangements.
• Multi-Gene Panels Carefully designed gene panels for various disease groups with parallel enrichment of multiple genes to cover overlapping clinical issues and differential diagnoses, with core and extended panel options, including detection of both SNVs and CNVs.
• Pränatale Diagnostik (Prenatal Diagnostics) Genetic diagnostic services designed for prenatal testing and counseling, addressing genetic concerns during pregnancy including advanced maternal age, abnormal ultrasound findings, and family history of genetic conditions, with quick turnaround for urgent cases.
• Präventivdiagnostik (Preventive Diagnostics) Preventive genetic testing aimed at identifying genetic predispositions before symptoms appear, supporting early intervention and risk assessment for patients and families.
• Humangenetische Beratung (Genetic Counseling) Genetic consultation services where experienced human genetics specialists discuss and clarify individual questions regarding genetically determined diseases, providing information on inheritance patterns, risks, and treatment options for patients and families.
• Videosprechstunde Humangenetik (Video Genetic Consultation) Online genetic consultation service enabling patients to receive genetic counseling remotely via video conference (Cisco WebEx or Zoom), expanding access to genetic services beyond in-person visits at the Mainz facility.
• Leistungsverzeichnis (Test Directory) Comprehensive catalog of available genetic tests and diagnostic services provided by the facility, including test descriptions, sample requirements, and turnaround information for referring physicians.

Quantifiable outcome

• Diagnostic yield of ~30% for pediatric chronic kidney disease cases and ~6-30% for adult cases using NGS-based testing
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and major.

• Nationale Allianz für seltene genetische Erkrankungen (NASGE)coreStrategic or Co-development PartnerFounding member of the National Alliance for Rare Genetic Diseases. The alliance aims to sustainably improve care for patients with rare diseases through nationwide cooperation of outpatient genetic centers. Offers interdisciplinary medical case discussions (Konsile) via video conference every four weeks.
• NEOCYST Consortium (BMBF Verbundprojekt)majorStrategic or Co-development PartnerNetwork on Early Onset CYSTic Kidney Disease research consortium. Interdisciplinary collaboration between renowned German centers, pediatric nephrology departments, geneticists, statisticians, and basic researchers working on diagnostic and therapeutic standards for cystic kidney diseases in children.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CeGaT GmbH: Tübingen-based German genomics services provider offering NGS-based panels, WES, WGS, and transcriptomics for clinical and research use. Highly comparable as a German-headquartered NGS diagnostics lab serving hospitals and physicians with a similar technology stack.
• MVZ genetikum: German human genetics MVZ providing genetic counseling, NGS panels, WES, and prenatal diagnostics. Operates the same MVZ-based clinical model with multi-gene panels and CNV detection, directly overlapping with Mainz's core offering.
• MVZ Humangenetik München / Martinsried: Munich-based medical genetics center providing hereditary disease diagnostics, genetic counseling, and NGS-based testing. Operates as a regional MVZ competitor to Mainz in the German outpatient human genetics market.
• Centogene N.V. Germany-based rare disease genomics company offering WES, WGS, and multi-gene panels globally. Comparable in NGS-based human genetics diagnostics with a strong rare disease emphasis — directly competitive in the same clinical genomics category.

Broad incumbents

• Eurofins Genomics: Genomics service division of Eurofins Scientific offering NGS, Sanger sequencing, and molecular biology services for clinical and research use. Comparable as a large-scale European genomics services provider with overlapping NGS and panel offerings.
• Bioscientia Institut für Medizinische Diagnostik: German clinical laboratory network offering a broad menu including human genetics, with multi-site operations. Comparable as a Limbach Gruppe-adjacent German lab offering genetic diagnostics as part of a wider specialty testing portfolio.
• Labcorp (Medizinische Genetik Mainz parent ecosystem): Global clinical laboratory network with growing European presence and genetic testing capabilities. Comparable as a broad incumbent that competes for complex genetic testing referrals and brings international scale to markets Limbach Gruppe serves.
• SYNLAB Group: Europe's largest medical diagnostics services provider with broad clinical and specialty testing including genetics. Comparable as a pan-European lab incumbent that competes for the same physician referral base and statutory health insurance volumes.

Emerging players

• Ambry Genetics: US-based clinical genetics lab specializing in hereditary cancer and rare disease NGS panels, WES, and WGS. Comparable in NGS-based clinical genetics services, though geographic and payor-system differences make it a partial, not direct, competitor.
• Invitae: US-based medical genetics company offering NGS-based panels, WES, and WGS for hereditary disease diagnosis. Comparable in clinical genomic test menu and digital-first ordering model, though operating in a different geographic and payor environment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medizinischegenetikmainz

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Limbach Genetics GmbH | Medizinische Genetik Mainz